Our results first suggested that REST expression was significantly positively correlated with immune cells, including B cells, CD8+ T cells, CD4+ immune cells, macrophages, neutrophils, and dendritic cells in glioma, as well as the particular biomarkers of these immune cells. The gene discussed is CD4; the disease is central nervous system cancer.